GSK says Dungarvan plant well-positioned for growth

Haleon will be created from the demerger of its consumer healthcare division from GSK
The panadol facility in Dungarvan has become one of the largest manufacturing sites in GSK’s consumer health network.

The panadol facility in Dungarvan has become one of the largest manufacturing sites in GSK’s consumer health network.

GlaxoSmithKline said its consumer healthcare venture with Pfizer will be named Haleon, as the drugmaker confirmed the business will be spun off in mid-2022 as planned.

Haleon will be created from the demerger of its consumer healthcare division from GSK. In Ireland, GSK Consumer Healthcare employs 930 people. 900 are located in Dungarvan, while a 30-strong sales and commercial team based in Dublin manages the company's portfolio of products. 

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited